Skip to search formSkip to main contentSkip to account menu

Amobarbital

Known as: 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, Amobarbital [Chemical/Ingredient] 
A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Background: Anosognosia (i.e., denial of hemiparesis) and asomatognosia (i.e., inability to recognize the affected limb as one’s… 
Highly Cited
1991
Highly Cited
1991
Abolition of speech production after intracarotid amobarbital injection is generally considered evidence for language laterality… 
Highly Cited
1979
Highly Cited
1979
Three experiments are reported testing two alternative hypotheses concerning the behavioural effects of sodium amylobarbitone (SA… 
Highly Cited
1977
Highly Cited
1977
1. Twenty anxious patients were treated with medazepam, diazepam, chlordiazepoxide, amylobarbitone and placebo, each given in… 
Highly Cited
1976
Highly Cited
1976
The effects of diazepam (2.5 and 5 mg) and amylobarbitone sodium (50 and 100 mg) on performance and subjective effects were… 
Highly Cited
1974
Highly Cited
1974
1 Following a single oral dose of amylobarbitone sodium it has been shown that a group of young subjects convert a higher… 
Highly Cited
1972
Highly Cited
1972
1 A single dose of amylobarbitone (3·23 mg/kg) was given by intravenous injection to each of ten healthy controls and two groups… 
Highly Cited
1966
Highly Cited
1966
IN previous experiments we found that, over a wide range of doses, amphetamine and amylobarbitone affected relatively little the…